Ligand validation:4XUQ

XYP: beta-D-xylopyranose

XYP is a Ligand Of Interest in 4XUQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XUQ_XYP_C_402	59%	40%	0.141	0.924	1.24	1.09	1	-	3	0	100%	1
4XUQ_XYP_C_401	56%	31%	0.126	0.914	0.63	2.07	-	5	3	0	90%	1
4XUQ_XYP_B_401	46%	41%	0.128	0.879	0.72	1.53	-	3	3	0	90%	1
4XUQ_XYP_A_1001	42%	24%	0.143	0.878	0.65	2.42	-	4	4	0	90%	1
4XUQ_XYP_B_402	36%	47%	0.172	0.864	0.95	1.09	1	2	3	0	100%	1
4XUR_XYP_B_1003	60%	35%	0.11	0.913	0.95	1.58	-	2	0	0	90%	1
1OD8_XYP_A_1311	100%	64%	0.047	0.992	0.75	0.64	-	-	0	0	100%	1
1V0M_XYP_A_1304	100%	71%	0.035	0.993	0.82	0.33	-	-	0	0	90%	1
8Y00_XYP_D_201	99%	28%	0.032	0.986	0.63	2.19	-	7	1	0	90%	1
2WYS_XYP_A_1001	99%	38%	0.052	0.983	0.69	1.7	-	4	3	0	100%	1
4PMY_XYP_A_401	99%	73%	0.051	0.979	0.49	0.57	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.